Topic Hub
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 14 of 14 clinical reviews.
A physician-reviewed guide to how low-dose naltrexone affects sleep, concentration, physical activity, and school performance in adolescents aged 12 to 17, with dosing context, timing strategies, and monitoring guidance.
Read clinical reviewA detailed caregiver guide to administering compounded low-dose naltrexone (LDN) to adolescents aged 12 to 17, including dosing protocols, timing, storage, side-effect monitoring, and when to contact the prescribing clinician.
Read clinical reviewA comprehensive clinical guide covering low-dose naltrexone (LDN) use in adolescents ages 12 to 17 and the steps needed for a safe, effective transition to adult care, including dosing, monitoring, and provider handoff protocols.
Read clinical reviewA clinician-reviewed guide to off-label low-dose naltrexone (LDN) use in adults aged 65 and older, covering dosing, drug interactions, evidence from named trials, and practical prescribing considerations for geriatric patients.
Read clinical reviewA clinical guide to low-dose naltrexone (LDN) use in geriatric patients, covering cognitive effects, physical activity, driving safety, fatigue management, and daily-life considerations for adults aged 65 and older.
Read clinical reviewBoard-reviewed caregiver guide to compounded low-dose naltrexone (LDN) in children under 12, covering dosing, timing, formulation, monitoring, and safety signals, with primary-source citations throughout.
Read clinical reviewA comprehensive clinical guide for caregivers managing low-dose naltrexone (LDN) in adults aged 65 and older, covering dosing, timing, storage, side-effect monitoring, and when to call the prescriber.
Read clinical reviewA clinical guide to low-dose naltrexone (LDN) use in adults 65 and older, covering dose adjustments, drug interactions, renal and hepatic considerations, and how to manage the transition from adult to geriatric care protocols.
Read clinical reviewA clinical review of low-dose naltrexone (LDN) use in adolescents aged 12 to 17, covering developmental safety, immune and neurological effects, dosing considerations, and what the current evidence actually shows.
Read clinical reviewA comprehensive clinical review of off-label low-dose naltrexone (LDN) use in adolescents aged 12 to 17, covering mechanism, dosing, evidence base, safety, and prescribing considerations.
Read clinical reviewA clinical review of low-dose naltrexone (LDN) for geriatric patients, covering immune modulation, neuroinflammation, dosing, safety, and the specific physiological changes that affect how adults 65+ respond to this compounded therapy.
Read clinical reviewA clinician-reviewed guide for parents and pediatric providers on how low-dose naltrexone affects school performance, physical activity, sleep, and daily routines in children under age 12.
Read clinical reviewA comprehensive clinical review of low-dose naltrexone (LDN) use in pediatric patients under age 12, covering neurodevelopmental effects, immune modulation, dosing considerations, and the current state of evidence.
Read clinical reviewA clinician-reviewed guide to managing low-dose naltrexone (LDN) in pediatric patients under 12, including dosing considerations, monitoring protocols, and a structured framework for transitioning to adult care providers.
Read clinical review